2015年12月10日星期四
Dextromoramide for sale
Product name:Dextromoramide
CAS:357-56-2
Molecular Formula:C25H32N2O2
Molecular Weight:392.534g/mol
Description:
Dextromoramide is a powerful opioid analgesic approximately three times more potent than morphine but shorter acting.It is subject to drug prohibition regimes, both internationally through UN treaties, and by the criminal law of individual states.The main advantage of this drug is that it has a fast onset of action when taken orally, and has a high bioavailability which means that oral dosing produces almost as much effect as injection.
Would like to ask specific details, please click here Email:sales@chemicalspharm.com
Dehydrocostus lactone
Product name:Dehydrocostus lactone
CAS:477-43-0
Molecular Formula:C15H18O2
Formula Weight:230.3
Description:
Boiling point:383.7 °C at 760 mmHg
Flash Point:161.2 °C
Density:1.09g/cm3|
Appearance:white powder.
Use:Serve as intermediates of medicine.
Storage:Store at room temperature.
Would like to ask specific details, please click here Email: sales@acridine-raw-material.com
How to buy 4-(Bromomethyl)benzaldehyde
Product name:4-(Bromomethyl)benzaldehyde
CAS:51359-78-5
Molecular Formula:C8H7BrO
Formula Weight:199.04
Description:
Melting point:99 °C
Boiling point:277.9°Cat760mmHg
Flash Point:107.1°C
Density:1.524g/cm3
Apperance:Colorless to light yellow crystal.
Solubility:Insouble in water.souble in alcohol and ether.
Use:Serve as intermediates of medicine and pesticides.
Would like to ask specific details, please click here Email:sales@acridine-raw-material.com
Epsilon-polylysine for sale
Product name:Epsilon-polylysine
CAS:25104-18-1
Molecular Formula:C18H36N6O3X2
Formula Weight:384.521
Description:
E-Polylysine is a natural substance from microbial metabolism.
It is widely used as food preservative. It can inhibit the growth of Gram(+) and Gram(-) bacteria such as E. Coli and Bacillus subtilis, yeast, lactic acid bacteria, Staphlacoccus aureus, ect...
Physical properties:
E-Polylysine is slightly bitter, hygroscopic, light yellow power.
It is soluble in water, slightly soluble in ethanol.
The molecular of E-Polylysine is a straight chain polymer of L-lysine.
Its activity is not affected by pH, and stable when heated (120C for 20 min).
Usage:
E-Polylysine was generally recognized as safe as food preservative by FDA in October, 2003.
It is widely used as food preservation in rice, noodles, cakes, snacks, and ice creams, salad, canned foods and meat products.
Would like to ask specific details, please click here Email:sales@acridine-raw-material.com
Tremuloidin for sale
Name: Tremuloidin
Catalog No: 3B3-004982
CAS No: 529-66-8
Molecular Formula: C20H22O8
Molecular Weight: 390.38
Description:
Purity: 98.0%
Would like to ask specific details, please click here Email:sales@pharmaceutical-intermediates.net
How to buy N-Deacetylcolchicine
Name: N-Deacetylcolchicine
Catalog No: 3B3-004990
CAS No:
Molecular Formula: C20H23NO5
Molecular Weight: 357.40
Description:
Purity: 98.0%
Would like to ask specific details, please click here Email:sales@pharmaceutical-intermediates.net
High drug prices smiling medical technology company?
Has become a problem of high drug prices from the United States government to the people have a headache. To solve this problem, up and down the US government have put forward their point of view. Even
drug prices problem has also become an important part of the US
presidential election, Hillary Clinton in September this year, will once
declared war high drug prices. For a time, the whole bio-pharmaceutical sector has suffered a significant impact. However, a boycott of the sound, medical technology companies and medical device companies can become a potential gainers.
Reuters reported that in the past few months, with Edwards Lifesciences, Boston Scientific and Becton Dickinson as the representative of the medical technology company on the stock's performance has gone beyond the average level of bio-pharmaceutical companies. September this year, Hillary Clinton a "declaration of war to high drug prices," the tweets to continue to push stock prices biomedical industry market poured cold water. In a few months time, the Nasdaq stock index has fallen biomedical exceed 5 percent. Thus, many analysts analysts believe medical device company stocks have better biological pharmaceutical stocks.
However, there are still some people have different views, the first medical device company optimistic about the market and a number of factors. Chief among them is the size of the elderly population increases due to increased market demand. Second, emerging market development so that the company's business began to increase significantly. Moreover, with high drug prices in stark contrast to recent years, medical equipment prices have been showing flat to down trend. Statistics 2008 --2014 years, many popular brands of drug prices rose twice as much. The price of medical devices places 2% -3% of the price decline year.
On the other hand, some analysts believe that the threat of high drug prices for pharmaceutical companies is far less serious than imagined. Albion Financial Group analyst on that although the prices of medicines caused by the nationwide discussion, but the company still tend to choose those with a groundbreaking new drugs pharmaceutical companies as potential investment targets. The best example is a new generation of hepatitis C drugs have been developed pharmaceutical giant Gilead.
Reuters reported that in the past few months, with Edwards Lifesciences, Boston Scientific and Becton Dickinson as the representative of the medical technology company on the stock's performance has gone beyond the average level of bio-pharmaceutical companies. September this year, Hillary Clinton a "declaration of war to high drug prices," the tweets to continue to push stock prices biomedical industry market poured cold water. In a few months time, the Nasdaq stock index has fallen biomedical exceed 5 percent. Thus, many analysts analysts believe medical device company stocks have better biological pharmaceutical stocks.
However, there are still some people have different views, the first medical device company optimistic about the market and a number of factors. Chief among them is the size of the elderly population increases due to increased market demand. Second, emerging market development so that the company's business began to increase significantly. Moreover, with high drug prices in stark contrast to recent years, medical equipment prices have been showing flat to down trend. Statistics 2008 --2014 years, many popular brands of drug prices rose twice as much. The price of medical devices places 2% -3% of the price decline year.
On the other hand, some analysts believe that the threat of high drug prices for pharmaceutical companies is far less serious than imagined. Albion Financial Group analyst on that although the prices of medicines caused by the nationwide discussion, but the company still tend to choose those with a groundbreaking new drugs pharmaceutical companies as potential investment targets. The best example is a new generation of hepatitis C drugs have been developed pharmaceutical giant Gilead.
订阅:
博文 (Atom)